Received the Grand Prize at the 5th Japan Entrepreneur Awards, sponsored by the Ministry of Economy, Trade and Industry
iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo; Representative Director and CEO, Kenichi Kono; Representative Director and COO, Motohisa Kaneko; hereafter iMed Technologies), which develops surgical support AI for endovascular therapy, has received the Grand Prize at the 5th Japan Entrepreneur Awards. See the following website for details.
iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo; Representative Director and CEO, Kenichi Kono; Representative Director and COO, Motohisa Kaneko; hereafter iMed Technologies), which develops surgical support AI for endovascular therapy, has received the Grand Prize at the 5th Japan Entrepreneur Awards.
See the following website for details. http://kenja-club.com/entrepreneur/2020/#winner
With this award as momentum, iMed Technologies will accelerate the commercialization of its surgical support AI for endovascular therapy.
■About iMed Technologies, Inc. Under the mission of “Delivering safe surgery to the world,” iMed Technologies develops surgical support AI for endovascular therapy.
■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for ischemic stroke and subarachnoid hemorrhage Representatives: Representative Director and CEO, physician Kenichi Kono Representative Director and COO, Motohisa Kaneko